This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
An FDA inspection, which took place between February 10-20, concluded with a cla...
Ratan Tata’s legacy goes beyond business, says author at Delhi Literature Festival
The acquisition was completed on a cash-free, debt-free basis, with an upfront c...
NTPC to raise ₹4,000 crore through non-convertible debentures (NCDs) on June 17,...
The financial results will be formally presented to the board on July 23 for fin...
Top 10@10 — CNBC-TV18’s daily newsletter featuring the top 10 stories on markets...
Ganorkar has been heading the India business of Sun Pharma since 2019 and will t...
Birla Corporation, as the highest bidder, has agreed to pay 20.60% of the value ...
The partnership marks a pivotal step in ENBEE’s ongoing efforts to strengthen it...
The Nifty PSU Bank Index is up over 6% so far this year, ahead of the Nifty 50’s...
Hindusthan Specialty Chemicals to break even in a year, says DCM Shriram’s Amit ...
Industry experts estimate total losses could reach ₹1,000 crore, including claim...
The Bombay court also questioned whether Celebi’s Turkish connection was the rea...
IREDA said the promoters of Gensol diluted their shareholdings without approval ...
This development follows the 29th Financial Stability and Development Council (F...
For years, the RBI’s tight grip has meant banks bore multiple costs—idle cash, f...
